sobuzoxane has been researched along with Adenocarcinoma, Papillary in 1 studies
sobuzoxane: used in treatment of leukemia L1210
Adenocarcinoma, Papillary: An adenocarcinoma containing finger-like processes of vascular connective tissue covered by neoplastic epithelium, projecting into cysts or the cavity of glands or follicles. It occurs most frequently in the ovary and thyroid gland. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " at the dose of 1,200 mg/body/day initially, and the dosage was modified thereafter depending on the grade of leukopenia." | 5.28 | [Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases]. ( Arimura, T; Fukuda, M; Katayama, K; Watanabe, H, 1991) |
| " at the dose of 1,200 mg/body/day initially, and the dosage was modified thereafter depending on the grade of leukopenia." | 1.28 | [Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases]. ( Arimura, T; Fukuda, M; Katayama, K; Watanabe, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukuda, M | 1 |
| Arimura, T | 1 |
| Katayama, K | 1 |
| Watanabe, H | 1 |
1 other study available for sobuzoxane and Adenocarcinoma, Papillary
| Article | Year |
|---|---|
[Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases].
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; | 1991 |